{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.5.201",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2020-09-02T01:00:24.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.201",
  "version": "20200902",
  "name": "Epirubicin",
  "status": "active",
  "date": "2020-09-02T01:00:24-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:9b4eadf3-a290-40d6-9dc9-98bdaf9833d9",
    "timestamp": "2022-09-27T20:37:48-04:00",
    "total": 2,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "code": "1732182",
        "display": "25 ML epirubicin hydrochloride 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "09062022",
        "code": "1732186",
        "display": "100 ML epirubicin hydrochloride 2 MG/ML Injection"
      }
    ]
  }
}